Somehow "clerk" is on my ublock origin blocklist and therefore the whole website is not loading. I didn't add "clerk" to the blocklist so it must've been added by one of the blocklists that ublock origin is subscribed to, so there must be a good reason why "clerk" is on that blocklist.
When building a product for medical audience which might care a lot about privacy maybe don't use components which are shady enough that they end up on blocklists.
Edit:
> Why no Vector DB? In medicine, "freshness" is critical. If a new trial drops today, a pre-indexed vector store might miss it. My real-time approach ensures the answer includes papers published today.
This is total rubbish - did you talk to a single medical practitioner when building this? Nobody will do new treatments on their patients if a new paper was "published" (whatever that means, just being added to some search index). These people require trusted source, experimental treatment is only done for private clients who have tried all other options.
Out of curiosity, what's the prioritization of evidence (RTC Metanalysis > RTC > observational ) etc, and what's the end user benefit over a tool like OpenEvidence? You mention that other tools are expensive, slow, or increasingly heavy with pharma ads, but OpenEvidence for now seems to be pretty similiar with offerings, speed, and responses. What's your pitch as to why one should prefer this?
Somehow "clerk" is on my ublock origin blocklist and therefore the whole website is not loading. I didn't add "clerk" to the blocklist so it must've been added by one of the blocklists that ublock origin is subscribed to, so there must be a good reason why "clerk" is on that blocklist.
When building a product for medical audience which might care a lot about privacy maybe don't use components which are shady enough that they end up on blocklists.
Edit:
> Why no Vector DB? In medicine, "freshness" is critical. If a new trial drops today, a pre-indexed vector store might miss it. My real-time approach ensures the answer includes papers published today.
This is total rubbish - did you talk to a single medical practitioner when building this? Nobody will do new treatments on their patients if a new paper was "published" (whatever that means, just being added to some search index). These people require trusted source, experimental treatment is only done for private clients who have tried all other options.
Out of curiosity, did you actually see any pharma ads on OpenEvidence?
Out of curiosity, what's the prioritization of evidence (RTC Metanalysis > RTC > observational ) etc, and what's the end user benefit over a tool like OpenEvidence? You mention that other tools are expensive, slow, or increasingly heavy with pharma ads, but OpenEvidence for now seems to be pretty similiar with offerings, speed, and responses. What's your pitch as to why one should prefer this?
FYI, You are using Clerk in development mode
Oof, good catch! I must have left the test keys active in the deployment config.
Swapping them to production keys right now. Thanks for the heads up!